LBH 10 mg (Farydak 10 mg)
Generic Name: panobinostat
Pill imprint LBH 10 mg has been identified as Farydak 10 mg.
Farydak is used in the treatment of multiple myeloma and belongs to the drug class histone deacetylase inhibitors. Farydak 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
Farydak
- Generic Name:
- panobinostat
- Imprint:
- LBH 10 mg
- Strength:
- 10 mg
- Color:
- Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Histone deacetylase inhibitors
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals Corporation
More about Farydak (panobinostat)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: histone deacetylase inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
